AWARD NUMBER: W81XWH-10-1-0062 TITLE: Discovery of Metastatic Breast Cancer Suppressor Genes Using Functional Genome Analysis PRINCIPAL INVESTIGATOR:

AWARD NUMBER: W81XWH-15-1-0044 TITLE: New Epigenetic Therapeutic Intervention for Metastatic Breast Cancer PRINCIPAL INVESTIGATOR:

Award Number: W81XWH-10-1-0338 TITLE: Investigating the Role of HOXC10 as a Mediator of Metastasis in Breast Cancer PRINCIPAL INVESTIGATOR:

AWARD NUMBER: W81XWH-04-1-0337 TITLE: Secondary lymphoid tissue chemokine as an immunotherapeutic against primary and metastatic breast cancer PRINCIPAL INVESTIGATOR:

AWARD NUMBER: W81XWH-15-1-0723 TITLE: Parathyroid Hormone-Related Peptide (PTHrP) as a New Target for Metastatic Breast Cancer: Evaluation in Preclinical Models PRINCIPAL INVESTIGATOR: Dr

Biocompatible, Biodegradable, and Enzymatic-Cleavable MRI Contrast Agents for Early Detection of Bone Metastatic Breast cancer PRINCIPAL INVESTIGATOR:

Award Number: W81XWH-11-1-0307 TITLE: Biocompatible, Biodegradable, and Enzymatic-Cleavable MRI Contrast Agents for Early Detection of Bone Metastatic Breast cancer PRINCIPAL INVESTIGATOR: Xuli Wang, Ph.D. CONTRACTING ORGANIZATION: University of Utah Salt Lake City, Utah 84112-8930 REPORT DATE: April 2013 TYPE OF REPORT: Final PREPARED FOR: U.S. Army Medical Research and Materiel Command Fort D...